ATC Group: A03BA01 Atropine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03BA01 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A03 Drugs for functional gastrointestinal disorders
4 A03BA Belladonna alkaloids, tertiary amines
5 A03BA01 Atropine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1.5 mg
PAREN - Parenteral 1.5 mg

Active ingredients in A03BA01

Active Ingredient Description

Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system.

Related product monographs

Title Information Source Document Type  
ATROPINE Eye drops Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ATROPINE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ATROPINE Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Brazil (BR)

Malta (MT)

Poland (PL)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.